EUR 8.0
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 2.27 Million EUR | -63.89% |
2022 | 6.29 Million EUR | -44.85% |
2021 | 11.4 Million EUR | 23.93% |
2020 | 9.2 Million EUR | 193.09% |
2019 | 3.13 Million EUR | 38.02% |
2018 | 2.27 Million EUR | -5.66% |
2017 | 2.41 Million EUR | -9.5% |
2016 | 2.66 Million EUR | -7.51% |
2015 | 2.88 Million EUR | 70.08% |
2014 | 1.69 Million EUR | 55.74% |
2013 | 1.08 Million EUR | -1.79% |
2012 | 1.1 Million EUR | -20.72% |
2011 | 1.39 Million EUR | 83.52% |
2010 | 761.16 Thousand EUR | 24.79% |
2009 | 609.96 Thousand EUR | 1.43% |
2008 | 601.34 Thousand EUR | -9.44% |
2007 | 664.04 Thousand EUR | -29.63% |
2006 | 943.7 Thousand EUR | 41.08% |
2005 | 668.9 Thousand EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 1.87 Million EUR | 0.0% |
2023 FY | 2.27 Million EUR | -63.89% |
2023 Q4 | 566.81 Thousand EUR | 0.0% |
2023 Q2 | 1.7 Million EUR | 0.0% |
2022 Q2 | 2.11 Million EUR | 0.0% |
2022 FY | 6.29 Million EUR | -44.85% |
2022 Q4 | 4.17 Million EUR | 0.0% |
2021 FY | 11.4 Million EUR | 23.93% |
2021 Q4 | 4.64 Million EUR | 0.0% |
2021 Q2 | 6.76 Million EUR | 0.0% |
2020 Q4 | 6.69 Million EUR | 0.0% |
2020 Q2 | 2.5 Million EUR | 0.0% |
2020 FY | 9.2 Million EUR | 193.09% |
2019 FY | 3.13 Million EUR | 38.02% |
2019 Q4 | 1.84 Million EUR | 0.0% |
2019 Q2 | 1.29 Million EUR | 0.0% |
2018 Q4 | 1.61 Million EUR | 0.0% |
2018 FY | 2.27 Million EUR | -5.66% |
2018 Q2 | 660.63 Thousand EUR | 0.0% |
2017 FY | 2.41 Million EUR | -9.5% |
2017 Q4 | 1.45 Million EUR | 0.0% |
2017 Q2 | 954.93 Thousand EUR | 0.0% |
2016 Q4 | 1.74 Million EUR | 0.0% |
2016 Q2 | 923.02 Thousand EUR | 0.0% |
2016 FY | 2.66 Million EUR | -7.51% |
2015 Q2 | 1.03 Million EUR | 0.0% |
2015 FY | 2.88 Million EUR | 70.08% |
2015 Q4 | 1.84 Million EUR | 0.0% |
2014 Q2 | 705.43 Thousand EUR | 0.0% |
2014 Q4 | 988.33 Thousand EUR | 0.0% |
2014 FY | 1.69 Million EUR | 55.74% |
2013 Q2 | 221.05 Thousand EUR | 0.0% |
2013 Q4 | 866.49 Thousand EUR | 0.0% |
2013 FY | 1.08 Million EUR | -1.79% |
2012 Q3 | 293.21 Thousand EUR | 0.0% |
2012 FY | 1.1 Million EUR | -20.72% |
2012 Q4 | 293.21 Thousand EUR | 0.0% |
2011 FY | 1.39 Million EUR | 83.52% |
2010 FY | 761.16 Thousand EUR | 24.79% |
2010 Q2 | 175.37 Thousand EUR | 0.0% |
2009 Q2 | 211.81 Thousand EUR | 0.0% |
2009 FY | 609.96 Thousand EUR | 1.43% |
2008 Q2 | 145.9 Thousand EUR | 0.0% |
2008 FY | 601.34 Thousand EUR | -9.44% |
2007 FY | 664.04 Thousand EUR | -29.63% |
2006 FY | 943.7 Thousand EUR | 41.08% |
2005 FY | 668.9 Thousand EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
CompuGroup Medical SE & Co. KGaA | 45.91 Million EUR | 95.053% |
MeVis Medical Solutions AG | 4.91 Million EUR | 53.828% |
Nexus AG | 24.03 Million EUR | 90.548% |